Investor Relations
Information disclosure Stock Information Presentation Materials and Newsletter Corporate Governance Investor Calendar Investor Enquiries
TAVR Commercialization Management Update
2021-07-02 16:14:20

全球领先“非醛交联”经导管主动脉干瓣系统1

Prev：Peijia Medical TAVR Guidance Update Call Presentation
Next：Peijia Medical 2021 Interim Results Presentation
Top